Hong Kong Use Chinese Test Kits which had High False-Positive Results in Sweden
The Hong Kong government will launch a universal testing programme on COVID-19 for no more than 2 weeks from September 1. However, BGI Genomics, one of the responsible agencies, was accused by the Swedish Public Health Agency that they received false-positive results on using BGI’s test kits. BGI Genomics stated that the test kits had undergone testing by authoritative organisations, and are one of the most sensitive reagents in the world, the sensitivity differs in countries.
The Swedish Public Health Agency had recorded 3,700 false-positive results from using BGI’s reagents and requested BGI Genomics to adjust the reagents to meet applicable standards. BGI Genomics responded, due to different sensitivity standards in different countries and regions, some asymptomatic carriers were determined as “healthy” in clinical manifestations. Therefore, high-sensitivity reagents would generate a positive test result, which would be regarded as “false positive”. BGI Genomics added that if the infected person participated in daily work or social activities as a “healthy” person, it would be harmful to the prevention and control of the epidemic.
#UniversalTesting #SwedishPublicHealthAgency #FalsePositive #BGIGenomics #COVID19
Source: Stand News #Aug26
https://bit.ly/2ETQJYq
The Hong Kong government will launch a universal testing programme on COVID-19 for no more than 2 weeks from September 1. However, BGI Genomics, one of the responsible agencies, was accused by the Swedish Public Health Agency that they received false-positive results on using BGI’s test kits. BGI Genomics stated that the test kits had undergone testing by authoritative organisations, and are one of the most sensitive reagents in the world, the sensitivity differs in countries.
The Swedish Public Health Agency had recorded 3,700 false-positive results from using BGI’s reagents and requested BGI Genomics to adjust the reagents to meet applicable standards. BGI Genomics responded, due to different sensitivity standards in different countries and regions, some asymptomatic carriers were determined as “healthy” in clinical manifestations. Therefore, high-sensitivity reagents would generate a positive test result, which would be regarded as “false positive”. BGI Genomics added that if the infected person participated in daily work or social activities as a “healthy” person, it would be harmful to the prevention and control of the epidemic.
#UniversalTesting #SwedishPublicHealthAgency #FalsePositive #BGIGenomics #COVID19
Source: Stand News #Aug26
https://bit.ly/2ETQJYq